Ovarian Hyperstimulation Syndrome

Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin

The Letrozole Administration During Luteal Phase

Freeze All Strategy Versus Fresh Embryo Transfer After GnRH Analogue Trigger

Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome

Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy

Montelukast for Prevention & Treatment of OHSS

Ovarian Hyperstimulation Syndrome Using Calcium Infusion

The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

Medical Assistance for the Procreation and Risk of Thrombosis.

Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response

Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS

Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response

Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers

The Influence of Timing of Cabergoline Initiation on Prevention of OHSS

Preventive Application of GnRH Antagonist on Early OHSS

Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET